scholarly journals Chromosomal instability in patients with Fanconi anemia from Serbia

2014 ◽  
Vol 71 (4) ◽  
pp. 368-372
Author(s):  
Sanja Cirkovic ◽  
Marija Guc-Scekic ◽  
Dragana Vujic ◽  
Dragan Micic ◽  
Dejan Skoric

Background/Aim. Fanconi anemia (FA) is a rare hereditary disease in a heterogeneous group of syndromes, so-called chromosome breakage disorders. Specific hypersensitivity of its cells to chemical agents, such as diepoxybutane (DEB), was used as a part of screening among patients with clinical suspicion of FA. The aim of this study was to determine chromosomal instability in patients with FA symptoms in Serbia. Methods. A total of 70 patients with phenotypic symptoms of FA, diagnosed at the Mother and Child Health Care Institute of Serbia ?Dr Vukan Cupic?, Belgrade and University Children?s Hospital, Belgrade from February 2004 to September 2011, were included in this study. Cytogenetic instability analysis was performed on untreated and DEBtreated 72 h-cultures of peripheral blood. Results. Ten patients in the group of 70 suspected of FA, showed increased DEB induced chromosome breakage and were classified into the FA group. The range of DEB induced aberrant cells percentages in the FA group was from 32% to 82%. DEB sensitivity of 58 tested patients were bellow FA values (range: 0-6%) (non-FA group), with no overlapping. The remaining two patients showed borderline sensitivity (borderline FA group - FA*), comparing to the healthy controls. Conclusion. This study revealed 10 patients with FA on the basis of cytogenetic analysis of DEB induced chromosome aberrations. Our results are in consistency with those from the literature. Early and precise diagnosis of FA is very important in further treatment of these patients, considering its cancer prone and lethal effects.

2006 ◽  
Vol 58 (4) ◽  
pp. 215-219
Author(s):  
Sanja Cirkovic ◽  
Marija Guc-Scekic ◽  
Dragana Vujic ◽  
D. Micic

Fanconi anemia (FA) is an inherited disorder with aplastic anemia, cancer susceptibility, and hypersensitivity to alkylating agents such as diepoxybutane (DEB). The DEB test is used to screen for FA among patients with bone marrow failure syndromes (BMFS). From February of 2004 to May of 2006, 29 children with BMFS were diagnosed and treated at the Mother and Child Health Care Institute of Serbia (MCHIS). In the examined group, five out of 29 patients (17.2%) were found to have increased DEB-induced chromosome breakage (0.58-2.15 vs. 0.00-0.20 breaks/cell; p<0.001) with no overlap. Our results suggest the importance of this analysis for differential diagnosis and adequate therapy of FA among patients with BMFS.


2005 ◽  
Vol 133 (1-2) ◽  
pp. 101-105
Author(s):  
Vladimir Pesic ◽  
Budimir Pavlovic ◽  
Jelena Jovanovic-Simic

Dr. Platon Papakostopulos (1864-1915), Dr. Milenko Materni (1875-1929), Dr. Milan Petrovic (1886-1963), Dr. Nadezda Stanojevic (1887-1979) and Dr. Djura Jovanovic (1892-1977) were founders of modern pediatrics in Serbia. They established and managed the first pediatric institutions: Hospital pediatric departments, Mother and Child Health Care Consultations and Child welfare clinics in Belgrade and Novi Sad. They also established Pediatric Section of the Serbian Medical Association and published numerous scientific and popular articles in pediatrics.


Sign in / Sign up

Export Citation Format

Share Document